제품 > 재조합 단백질

Recombinant SARS-CoV-2 Nucleocapsid(G335A) Protein (RP01281LQ)

Bioactivityvalidated

Datasheet

Overview

Product nameRecombinant SARS-CoV-2 Nucleocapsid(G335A) Protein
Catalog No.RP01281LQ
DescriptionRecombinant SARS-CoV-2 Nucleocapsid(G335A) Protein is produced by Baculovirus-Infected Sf9 Cells expression system. The target protein is expressed with sequence (Ser2-Ala419(Gly335Ala)) of sars-cov-2 Nucleocapsid (Accession #QHD43423.2) fused with a 6×His tag at the N-terminus.
Bio-Activity1.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid Protein at 2 μg/mL (100 μL/well) can bind SARS-CoV-2 N Protein Rabbit mAb with a linear range of 0.032-0.79 ng/mL.
2.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 envelope Protein at 2 μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid protein, the EC50 of Recombinant SARS-CoV-2 Nucleocapsid protein is 46.90 ng/mL.
Purity> 90% by SDS-PAGE.
Endotoxin< 0.1 EU/μg of the protein by LAL method.
FormulationSupplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0.Contact us for customized product form or formulation.
SpeciesSARS-CoV-2
Calculated MW46.35 kDa
SynonymNucleoprotein
Expression HostBaculovirus-Infected Sf9 Cells
TagN-His
Swiss-Prot
Gene ID
StorageStore at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles.

* For research use only. Not for therapeutic or diagnostic purposes.

용량을 선택하세요
문의하기